Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer
Author:
Affiliation:
1. Centre for Cancer and Inflammation Research, School of Chinese Medicine Hong Kong Baptist University Hong Kong China
2. International Institute for Translational Chinese Medicine Guangzhou University of Chinese Medicine Guangzhou Guangdong China
Funder
Innovation and Technology Commission
National Natural Science Foundation of China
Publisher
Wiley
Subject
Molecular Medicine,Medicine (miscellaneous)
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.564
Reference10 articles.
1. Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model
2. Multiple Roles of Toll-Like Receptor 4 in Colorectal Cancer
3. Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications
4. Clinicopathological Significances of Tumor–Stroma Ratio (TSR) in Colorectal Cancers: Prognostic Implication of TSR Compared to Hypoxia-Inducible Factor-1α Expression and Microvessel Density
5. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hsa-miR-483-5p/mRNA network that regulates chemotherapy resistance in locally advanced rectal cancer identified through plasma exosome transcriptomics;World Journal of Clinical Oncology;2024-08-24
2. The most recent progress of baicalein in its anti-neoplastic effects and mechanisms;Biomedicine & Pharmacotherapy;2024-07
3. Pharmacodynamic Materials and Mechanisms of Compound Scutellariae Radix Granules for Colorectal Cancer: A Network Pharmacology, Molecular Docking and Cell Experiments Study;Natural Product Communications;2024-07
4. The Role of Natural Products from Herbal Medicine in TLR4 Signaling for Colorectal Cancer Treatment;Molecules;2024-06-07
5. Role of natural secondary metabolites as HIF-1 inhibitors in cancer therapy;Medicinal Chemistry Research;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3